EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
2.3.1.20 | Adrenocortical Carcinoma |
34353633 |
Identification of novel lipid metabolic biomarkers associated with poor adrenocortical carcinoma prognosis using integrated bioinformatics. |
causal interaction diagnostic usage unassigned |
3 4 0 |
2.3.1.20 | Alopecia |
15569818 |
Inhibition of triglyceride synthesis as a treatment strategy for obesity: lessons from DGAT1-deficient mice. |
causal interaction ongoing research therapeutic application unassigned |
4 2 4 0 |
2.3.1.20 | Alopecia |
19028692 |
Retinol Esterification by DGAT1 Is Essential for Retinoid Homeostasis in Murine Skin. |
causal interaction therapeutic application unassigned |
3 1 0 |
2.3.1.20 | Alopecia |
25112279 |
Pharmacological inhibition of DGAT1 induces sebaceous gland atrophy in mouse and dog skin while overt alopecia is restricted to the mouse. |
causal interaction ongoing research therapeutic application unassigned |
3 2 4 0 |
2.3.1.20 | Arthritis |
23695883 |
Arthritis severity locus Cia4 is an early regulator of IL-6, IL-1?, and NF-?B activators' expression in pristane-induced arthritis. |
unassigned |
0 |
2.3.1.20 | Atherosclerosis |
17614133 |
Potential therapeutics for obesity and atherosclerosis: inhibitors of neutral lipid metabolism from microorganisms. |
causal interaction unassigned |
1 0 |
2.3.1.20 | Atherosclerosis |
21045115 |
Vascular gene expression in mice overexpressing human endothelin-1 targeted to the endothelium. |
ongoing research unassigned |
1 0 |
2.3.1.20 | Atherosclerosis |
21924378 |
Lack of acyl-CoA:diacylglycerol acyltransferase 1 reduces intestinal cholesterol absorption and attenuates atherosclerosis in apolipoprotein E knockout mice. |
causal interaction ongoing research therapeutic application unassigned |
4 2 3 0 |
2.3.1.20 | Atherosclerosis |
32882484 |
Intestine-specific DGAT1 deficiency improves atherosclerosis in apolipoprotein E knockout mice by reducing systemic cholesterol burden. |
causal interaction ongoing research therapeutic application unassigned |
4 3 1 0 |
2.3.1.20 | Brain Neoplasms |
33235909 |
DGAT1 protects tumor from lipotoxicity, emerging as a promising metabolic target for cancer therapy. |
causal interaction diagnostic usage ongoing research therapeutic application |
3 1 2 4 |